FDA label
What is Venclexta used for?
Venclexta contains venetoclax. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Venclexta lists 2 uses: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Acute Myeloid Leukemia.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Venclexta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Venclexta, tablet, film coated
Indications and Usage, quoted from the label by AbbVie Inc. (NDA208573). Cross-references to other label sections are left out.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Acute Myeloid Leukemia
VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
Source: DailyMed label, set id b118a40d-6b56-cee3-10f6-ded821a97018, version 283, effective May 20, 2026. NDC 0074-0561, one of 3 listings for this product.
Questions
What is Venclexta used for?
The FDA label for Venclexta lists 2 uses: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Acute Myeloid Leukemia.
What drug class is Venclexta?
FDA lists venetoclax in the BCL-2 Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.